Guillouzo A[au] - Search Results

Year	Number of Results
1969	1
1970	1
1971	2
1972	2
1973	3
1974	2
1975	4
1976	2
1977	3
1978	2
1979	5
1980	5
1981	4
1982	5
1983	6
1984	8
1985	7
1986	4
1987	4
1988	15
1989	7
1990	15
1991	15
1992	6
1993	16
1994	11
1995	10
1996	16
1997	10
1998	13
1999	14
2000	10
2001	13
2002	12
2003	8
2004	4
2005	5
2006	4
2007	3
2008	8
2009	8
2010	9
2011	6
2012	4
2013	2
2014	7
2015	8
2016	3
2017	5
2018	3
2019	4
2020	1
2021	0

1

Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models.

Weaver RJ, Blomme EA, Chadwick AE, Copple IM, Gerets HHJ, Goldring CE, Guillouzo A, Hewitt PG, Ingelman-Sundberg M, Jensen KG, Juhila S, Klingmüller U, Labbe G, Liguori MJ, Lovatt CA, Morgan P, Naisbitt DJ, Pieters RHH, Snoeys J, van de Water B, Williams DP, Park BK. Weaver RJ, et al. Among authors: guillouzo a. Nat Rev Drug Discov. 2020 Feb;19(2):131-148. doi: 10.1038/s41573-019-0048-x. Epub 2019 Nov 20. Nat Rev Drug Discov. 2020. PMID: 31748707 Review.

2

The P-glycoprotein multidrug transporter.

Fardel O, Lecureur V, Guillouzo A. Fardel O, et al. Among authors: guillouzo a. Gen Pharmacol. 1996 Dec;27(8):1283-91. doi: 10.1016/s0306-3623(96)00081-x. Gen Pharmacol. 1996. PMID: 9304397 Review.

3

Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.

Berthou L, Duverger N, Emmanuel F, Langouët S, Auwerx J, Guillouzo A, Fruchart JC, Rubin E, Denèfle P, Staels B, Branellec D. Berthou L, et al. Among authors: guillouzo a. J Clin Invest. 1996 Jun 1;97(11):2408-16. doi: 10.1172/JCI118687. J Clin Invest. 1996. PMID: 8647932 Free PMC article.

4

Evolving concepts in liver tissue modeling and implications for in vitro toxicology.

Guillouzo A, Guguen-Guillouzo C. Guillouzo A, et al. Expert Opin Drug Metab Toxicol. 2008 Oct;4(10):1279-94. doi: 10.1517/17425255.4.10.1279. Expert Opin Drug Metab Toxicol. 2008. PMID: 18798698 Review.

5

The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.

Guillouzo A, Corlu A, Aninat C, Glaise D, Morel F, Guguen-Guillouzo C. Guillouzo A, et al. Chem Biol Interact. 2007 May 20;168(1):66-73. doi: 10.1016/j.cbi.2006.12.003. Epub 2006 Dec 16. Chem Biol Interact. 2007. PMID: 17241619 Review.

6

Isolation of a cyp2b10-like cDNA and of a clone derived from a cyp2b10-like pseudogene.

Marc N, Damon M, Fautrel A, Guillouzo A, Corcos L. Marc N, et al. Among authors: guillouzo a. Biochem Biophys Res Commun. 1999 Apr 29;258(1):11-6. doi: 10.1006/bbrc.1999.0585. Biochem Biophys Res Commun. 1999. PMID: 10222226

7

Setup and Use of HepaRG Cells in Cholestasis Research.

Guguen-Guillouzo C, Guillouzo A. Guguen-Guillouzo C, et al. Among authors: guillouzo a. Methods Mol Biol. 2019;1981:291-312. doi: 10.1007/978-1-4939-9420-5_19. Methods Mol Biol. 2019. PMID: 31016662

8

Stem cell-derived hepatocytes and their use in toxicology.

Guguen-Guillouzo C, Corlu A, Guillouzo A. Guguen-Guillouzo C, et al. Among authors: guillouzo a. Toxicology. 2010 Mar 30;270(1):3-9. doi: 10.1016/j.tox.2009.09.019. Epub 2009 Oct 6. Toxicology. 2010. PMID: 19815049 Review.

9

New challenges in hepatic fibrosis.

Clément B, Loréal O, Levavasseur F, Guillouzo A. Clément B, et al. Among authors: guillouzo a. J Hepatol. 1993 Apr;18(1):1-4. doi: 10.1016/s0168-8278(05)80002-9. J Hepatol. 1993. PMID: 8340600 Review.

10

General review on in vitro hepatocyte models and their applications.

Guguen-Guillouzo C, Guillouzo A. Guguen-Guillouzo C, et al. Among authors: guillouzo a. Methods Mol Biol. 2010;640:1-40. doi: 10.1007/978-1-60761-688-7_1. Methods Mol Biol. 2010. PMID: 20645044 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results